본문 바로가기
KERD
논문KCI 등재

Nanoparticle-Based Medical Therapy and Research

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Recently, a variety of nanoparticles have been considered as an attractive way that is effective and helpful in diagnosis and treatment of cancer and diseases through development in nanoscience and nanotechnology. Nanoparticles refer to tiny particles between 100 nm and 1 μm. The objective of this paper is to review the current applications, the research trend, and the possibility in future of the metallic nanoparticles in drug delivery, imaging, therapy, and combined imaging and therapy, as well as hearing research. The nanoparticles for effective drug delivery have been used to selectively target and kill the cancer cells or tumor cells and to transport molecules, nanoparticles, and cells into solid tumors in chemotherapy and radiation. The nanoparticles in hearing research have been used to prevent or treat the noise-, ototoxicity-, inflammatory-, viral-, and immune-mediated hearing loss and cell death processes using genetic and trophic factors enhancing repair processes of hair cell in the cochlea. The nanoparticles for effective imaging have been used to confirm a detailed view of targeting in live cells and their interactions with intracellular molecules and as contrast agents for CT, MRI, and x-ray imaging. The nanoparticles in therapy have been used in chemotherapy, immunotherapy, radiotherapy, thermotherapy, and photodynamic therapy by targeting the fast growing cells, blocking some critical elements of the cell division process, transporting various compositions, and increasing the dose and effectiveness of x-rays. Recently, the nanoparticles have been used to increase the effectiveness of individual modality image or therapy by combining noninvasive multimodality imaging and molecular therapy. This method can provide a new insight and intuition on the diagnosis and treatment of the various cancers and diseases including hearing loss.

Abstract

Recently, a variety of nanoparticles have been considered as an attractive way that is effective and helpful in diagnosis and treatment of cancer and diseases through development in nanoscience and nanotechnology. Nanoparticles refer to tiny particles between 100 nm and 1 μm. The objective of this paper is to review the current applications, the research trend, and the possibility in future of the metallic nanoparticles in drug delivery, imaging, therapy, and combined imaging and therapy, as well as hearing research. The nanoparticles for effective drug delivery have been used to selectively target and kill the cancer cells or tumor cells and to transport molecules, nanoparticles, and cells into solid tumors in chemotherapy and radiation. The nanoparticles in hearing research have been used to prevent or treat the noise-, ototoxicity-, inflammatory-, viral-, and immune-mediated hearing loss and cell death processes using genetic and trophic factors enhancing repair processes of hair cell in the cochlea. The nanoparticles for effective imaging have been used to confirm a detailed view of targeting in live cells and their interactions with intracellular molecules and as contrast agents for CT, MRI, and x-ray imaging. The nanoparticles in therapy have been used in chemotherapy, immunotherapy, radiotherapy, thermotherapy, and photodynamic therapy by targeting the fast growing cells, blocking some critical elements of the cell division process, transporting various compositions, and increasing the dose and effectiveness of x-rays. Recently, the nanoparticles have been used to increase the effectiveness of individual modality image or therapy by combining noninvasive multimodality imaging and molecular therapy. This method can provide a new insight and intuition on the diagnosis and treatment of the various cancers and diseases including hearing loss.

참고문헌 (79)

  1. Abou-Jawde, R., "An overview of targeted treatments in cancer", Clinical Therapeutics, 25, pp.2121~2137 (2003)
  2. Adams, J. C., "Clinical implications of inflammatory cytokines in the cochlea: A technical note", Otology & Neurotology, 23, pp.316~322 (2002)
  3. Alric, C., "Gold nanoparticles desiged for combining dual modality imaging and radiotherapy", Gold Bulletin, 41, pp.90~97 (2008)
  4. Bhadra, D., "A PEGylated dendritic nanoparticulate carrier of fluorouracil", International Journal of Pharmaceutics, 257, pp.111~124 (2003)
  5. Boal, A. K., "Self-assembly of nanoparticles into structured spherical and network aggregates", Nature, 404, pp.746~748 (2000)
  6. Brannon-Peppas, L., "Nanoparticle and targeted systems for cancer therapy", Advanced Drug Delivery Reviews, 56, pp.1649~1659 (2004)
  7. Brigger, I., "Nanoparticles in cancer therapy and diagnosis", Advanced Drug Delivery Reviews, 54, pp.631~651 (2002)
  8. Cai, Q-Y., "Colloidal gold nanoparticles as a bloodpool contrast agent for x-ray computed tomography in mice", Investigative Radiology, 42, pp.797~806 (2007)
  9. Cai, W., "Nanoplatforms for targeted molecular imaging in living subjects", Small, 11, pp.1840~1854 (2007)
  10. Chakrabarti, R., "Nanocrystals modified with peptide nuclei acids(PNAs)for selective self-assembly and DNA detection", Journal of the American Chemical Society, 125, pp.12531~12540 (2003)
  11. Chen, Q-R., "Targeting tumor angiogenesis with gene therapy", Molecular Genetics and Metabolism, 74, pp.120~127 (2001)
  12. Chien, C. C., "Synchrotron x-ray synthesized gold nanoparticles for tumor therapy", Synchrotron Radiation Instrumentation: Ninth International Conference, 9, pp.1908~1911 (2007)
  13. Chithrani, B. D., "Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells", Nano Letter, 6, pp.662~668 (2006)
  14. Cormode, D. P., "Nanotechnology in medical imaging: probe design and applications. Arteriosclerosis", Thrombosis, and Vascular Biology, 29, pp.992~1000 (2009)
  15. de Lussanet, Q. G., "Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice", Radiology, 235, pp.65~72 (2005)
  16. Ding, Y., "A piezoelectric immunosensor for the detector of alpha-fetoprotein using an interface of gold", hydroxyapatite hybrid nanomaterial, 2007, pp.28, 2147~2154
  17. Eatock, M. M., "Tumor vasculature as a target for anticancer therapy", Cancer Treatment Reviews, 26, pp.191~204 (2000)
  18. El-Sayed, I. H., "Selective laser photo-thermal therapy of epithelial carcinoma using anti- EGFR antibody conjugated gold nanoparticles", Cancer Letter, 239, pp.129~135 (2006)
  19. Fox, S. B., "Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer", Cancer Research, 53, pp.4161~4163 (1993)
  20. Frankamp, B. L., "Recognition-mediated assembly of nanoparticles into micellar structures with diblock copolymers", Journal of the American Chemical Society, 124, pp.892~893 (2002)
  21. Gannon, C. J., "Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells", Journal of Nanobiotechnology, 6, pp.1~9 (2008)
  22. Gaur, U., "Biodistributution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system", International Journal of Pharmaceutics, 202, pp.1~10 (2000)
  23. Goodman, C. M., "Toxicity of gold nanoparticles functionalized with cationic and anionic side chains", Bioconjugate Chemistry, 15, pp.897~900 (2004)
  24. Guo, T., "WO06037081A2", ~ (2006)
  25. Hainfeld, J. F., "Gold nanoparticles: a new X-ray contrast agent", British Journal of Radiology, 79, pp.248~253 (2006)
  26. Han, G., "Multi-functional gold nanoparticles for drug delivery", Advances in Experimental Medicine & Biology, 620, pp.48~56 (2007)
  27. Hirsch, L. R., "Whole-blood immunoassay facilitated by gold nanoshell-conjugate antibodies", Methods in Molecular Biology, 303, pp.101~111 (2005)
  28. Hobson, B., "Endothelial proliferation in tumors and normal tissues: continuous labeling studies", British Journal of Cancer, 49, pp.405~413 (1984)
  29. Huang, S., "Gold nanoparticle-based immunochromatographic tet for identification of Staphylococcus aureus from clinical specimens", Clinica Chimicha Acta, 373, pp.139~143 (2006)
  30. Huang, T., "Oxidative stress-induced apoptosis of cohlear sensoty cells: protective strategies", International Journal of Developmental Neuroscience, 18, pp.259~270 (2000)
  31. Huang, X., "Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods", Journal of the American Chemical Society, 128, pp.2115~2120 (2006)
  32. Hyafil, F., "Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography", Nature Medicine, 13, pp.636~641 (2007)
  33. Ingber, D. E., "Fibronectin controls capillary endothelial cells growth by modulating cell shape", Proceedings of the National Academy of Sciences of the United States of America, 87, pp.3579~3583 (1990)
  34. Jain, R. K., "Transport of molecules, particles, and cells in solid tumors", Annual Review of Biomedical Engineering, 1, pp.241~263 (1999)
  35. Kircheis, R., "Coupling of cell-binding ligands to polythylenimine for targeted gene transfer", Gene Therapy, 4, pp.409~418 (1997)
  36. Kohler, G., "Continuous cultures of fuse cells secreting antibody of predefined specificity", 381-394, 75(Suppl.1), pp.381~394 (1975)
  37. Kopke, R. D., "Targeted topical steroid therapy in sudden sensorineural hearing loss", Otology & Neurotology, 22, pp.475~479 (2001)
  38. Kopke, R. D., "Magnetic nanoparticles: Inner ear targeted molecule delivery and middle ear implant", Audiology & Neurotology, 11, pp.123~133 (2006)
  39. Kroft, L. J., "Blood pool contrast agents for cardiovascular MR imaging", Journal of Magnetic Resonance Imaging, 10, pp.395~403 (1999)
  40. Lanza, G. M., "Molecular imaging in MR with targeted paramagnetic nanoparticles", Medicamundi, 47, pp.34~39 (2003)
  41. Levy, R., "Gold nanoparticles delivery in mammalian live cells: a critical view", Nano Reviews, 1, pp.4889~4903 (2010)
  42. Lewin, M., "Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells", Nature Biotechnology, 18, pp.410~414 (2000)
  43. Lin, C. A. J., "Synthesis, characterization, and bioconjugation of fluorescent gold nanoclusters toward biological labeling applications", ACS Nano, 3, pp.395~401 (2009)
  44. Loo, C., "Immunotargeted nanoshells for integrated cancer imaging and therapy", Nano Letter, 5, pp.709~711 (2005)
  45. Lorenz, C. H., "Contrast-enhanced coronary MRA", Journal of Magnetic Resonance Imaging, 10, pp.703~708 (1999)
  46. Louie, A. Y., "In vivo visualization of gene expression using magnetic resonance imaging", Nature Biotechnology, 18, pp.321~325 (2000)
  47. Lutz, A. M., "Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging", Radiology, 233, pp.149~157 (2004)
  48. Mclntosh, C. M., "Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters", Journal of the American Chemical Society, 123, pp.7626~7629 (2001)
  49. Medarova, Z., "In vivo imaging of siRNA delivery and silencing in tumors", Nature Medicine, 13, pp.372~377 (2007)
  50. Medarova, Z., "In vivo imaging of tumor response to therapy using a dual-modality imaging strategy", International Journal of Cancer, 118, pp.2796~2802 (2006)
  51. Mukherjee, P., "Antiangiogenic properties of gold nanoparticles", Clinical Cancer Research, 11, pp.3530~3534 (2005)
  52. Mulder, W. J. M., "Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging", NMR Biomedicine, 19, pp.142~164 (2006)
  53. Nagesha, D., "In vitro imaging of embryonic stem cells using multiphoton luminescence of gold nanoparticles", International Journal of Nanomedicine, 2(3), pp.813~819 (2007)
  54. Niidome, T., "PEG-modified gold nanorods with a stealth character for in vivo applications", Journal of Controlled Release, 114, pp.343~347 (2006)
  55. Paciotti, G. F., "Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery", Drug Delivery, 11(3), pp.169~183 (2004)
  56. Padhani, A. R., "Dynamic contrast-enhanced MRI in clinical oncology: Current status and future directions", Journal of Magnetic Resonance Imaging, 16, pp.407~422 (2002)
  57. Pissuwan, D., "Therapeutic possibilities of plasmonically heated gold nanoparticles", Trends in Biotechnology, 24, pp.62~67 (2006)
  58. Praetorius, N. P., "Engineered nanoparticles in cancer therapy", Recent on Drug Delivery & Formulation, 1, pp.37~51 (2007)
  59. Reynolds, A. R., "Nanoparticles-mediated gene delivery to tumor vasculature", Trends in Molecular Medicine, 9, pp.2~4 (2003)
  60. Ruehm, S. G., "Magnetic resonant imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits", Circulation, 103, pp.415~422 (2001)
  61. Saha, A., "Functionalized plasmonic-fluorescent nanoparticles for imaging and detection", The Journal of Physical Chemistry C, 113, pp.18492~18498 (2009)
  62. Seidman, M., "Pharmacologic manipulation of the labyrinth with novel and traditional agents delivered to the inner ear", Ear, Nose, & Throat Journal, 82, pp.276~280 (2003)
  63. Sepp, N., "Endothelial cells and angiogenesis", Experimental Dermatology, 6, pp.272~273 (1997)
  64. Shukla, R., "Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview", Langmuir, 21, pp.10644~10654 (2005)
  65. Simon-Deckers, A., "Impact of gold nanoparticles combined to X-ray irradiation on bacteria", Gold Bulletin, 41, pp.187~194 (2008)
  66. Singla, A. K., "Paclitaxel and its formulations", International Journal of Pharmaceutics, 235, pp.179~192 (2002)
  67. Sipkins, D. A., "Detection of tumor an giogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging", Nature Medine, 4, pp.623~626 (1994)
  68. Sledge, G., "Exploiting the hallmarks of cancer: the future conquest of breast cancer", European Journal of Cancer, 39, pp.1668~1675 (2003)
  69. Song, B. B., "Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo", Journal of Pharmacology and Experimental Therapeutics, 282, pp.369~377 (1997)
  70. Storm, G., "Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system", Advanced Drug Delivery Reviews, 17, pp.31~48 (1995)
  71. Suzawa, T., "Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene-glycol)-based cleavable linker", Journal of Controlled Release, 79, pp.229~242 (2002)
  72. Thomas, M., "Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells", Proceedings of the National Academy of Science of the United States of America, 100, pp.9138~9143 (2003)
  73. Tkachenko, A. G., "Mltifunctional gold nanoparticle-peptide complexes for nuclear targeting", Journal of the American Chemical Society, 125, pp.4700~4701 (2003)
  74. Veldhuis, W. B., "Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption", Journal of Cerebral Blood Flow & Metabolism, 23, pp.1060~1069 (2003)
  75. Wickline, S. A., "Nanotechnology for molecular imaging and targeted therapy", Circulation, 107, pp.1092~1095 (2011)
  76. Williams, J., "Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors", Journal of Controlled Release, 91, pp.167~172 (2003)
  77. Wisner, E. R., "Long-term effect of irradiation on lymph node uptake of interstitially delivered nanoparticulate contrast media", Investigative Radiology, 35, pp.199~204 (2000)
  78. Yoo, H. S., "In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates", Polymer Preparation, 41, pp.992~993 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (9건)